Suppr超能文献

疾病预防与健康促进的经济评价方法学问题:系统评价和范围综述概述。

Methodological issues in economic evaluations of disease prevention and health promotion: an overview of systematic and scoping reviews.

机构信息

Institute for Health Economics and Clinical Epidemiology, Faculty of Medicine and University Hospital of Cologne, Gleueler Str. 176-178, 50935, Cologne, Germany.

出版信息

BMC Public Health. 2021 Nov 20;21(1):2130. doi: 10.1186/s12889-021-12174-w.

Abstract

BACKGROUND

We aimed to provide a comprehensive overview of methodological challenges in economic evaluations of disease prevention and health promotion (DPHP)-measures.

METHODS

We conducted an overview of reviews searching MEDLINE, EMBASE, NHS Economic Evaluation Database, Database of Promoting Health Effectiveness Reviews, Cochrane Database of Systematic Reviews (CDSR) and Database of Promoting Health Effectiveness Reviews (DOPHER) (from their inception to October 2021). We included both systematic and scoping reviews of economic evaluations in DPHP addressing following methodological aspects: (i) attribution of effects, (ii) outcomes, (iii) inter-sectoral (accruing to non-health sectors of society) costs and consequences and (iv) equity. Data were extracted according to the associated sub-criteria of the four methodological aspects including study design economic evaluation (e.g. model-based), type/scope of the outcomes (e.g. outcomes beyond health), perspective, cost categories related to non-health sectors of society, and consideration of equity (method of inclusion). Two reviewers independently screened all citations, full-text articles, and extracted data. A narrative synthesis without a meta-analysis or other statistical synthesis methods was conducted.

RESULTS

The reviewing process resulted in ten systematic and one scoping review summarizing 494 health economic evaluations. A lifelong time horizon was adopted in about 23% of DPHP evaluations, while 64% of trial-based evaluations had a time horizon up to 2 years. Preference-based outcomes (36%) and non-health outcomes (8%) were only applied in a minority of studies. Although the inclusion of inter-sectoral costs (i.e. costs accruing to non-health sectors of society) has increased in recent years, these were often neglected (between 6 and 23% depending on the cost category). Consideration to equity was barely given in economic evaluations, and only addressed in six of the eleven reviews.

CONCLUSIONS

Economic evaluations of DPHP measures give only little attention to the specific methodological challenges related to this area. For future economic DPHP evaluations a tool with structured guidance should be developed. This overview of reviews was not registered and a published protocol does not exist.

摘要

背景

本研究旨在全面概述疾病预防和健康促进(DPHP)措施的经济评估中存在的方法学挑战。

方法

我们对 MEDLINE、EMBASE、NHS 经济评价数据库、促进健康效果评价数据库、Cochrane 系统评价数据库(CDSR)和促进健康效果评价数据库(DOPHER)进行了综述,检索时间从数据库建立至 2021 年 10 月。我们纳入了 DPHP 领域内的经济评估系统评价和范围评价,涵盖以下方法学方面:(i)效果归因,(ii)结果,(iii)跨部门(社会非卫生部门产生的)成本和后果,以及(iv)公平性。根据四个方法学方面的相关亚标准提取数据,包括经济评价研究设计(如基于模型的)、结果类型/范围(如健康以外的结果)、视角、与社会非卫生部门相关的成本类别,以及对公平性的考虑(纳入方法)。两位审查员独立筛选所有引文、全文文章和提取数据。进行了无荟萃分析或其他统计综合方法的叙述性综合。

结果

审查过程产生了十项系统评价和一项范围评价,共总结了 494 项卫生经济评估。大约 23%的 DPHP 评估采用了终身时间范围,而 64%的基于试验的评估时间范围为 2 年以内。偏好结果(36%)和非健康结果(8%)仅在少数研究中应用。尽管近年来纳入了跨部门成本(即社会非卫生部门产生的成本),但这些成本经常被忽视(取决于成本类别,在 6%至 23%之间)。在经济评估中几乎没有考虑公平性,仅有 11 项综述中的 6 项考虑了公平性。

结论

DPHP 措施的经济评估对该领域特有的方法学挑战关注甚少。未来的 DPHP 经济评估应开发具有结构化指导的工具。本综述未进行注册,也没有发表的方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b684/8605499/8b3074674650/12889_2021_12174_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验